Related Experiment Video
Updated: Oct 5, 2026

Transurethral Induction of Mouse Urinary Tract Infection
Published on: August 5, 2010
Single-dose treatment of lower urinary tract infections with fosfomycin trometamol: preliminary experiences
Abstract:
In recent years many clinical trials were carried out in order to evaluate the efficacy of single dose therapy in lower urinary tract infections (UTIs). In this trial we treated 26 patients (5 M and 21 F) suffering from lower UTI with an single oral dose of 3 g of fosfomycin trometamol, a new phosphonic acid derivative. The overall cure rate four weeks after treatment was 77% (20 out of 26 patients). A cure rate of 89% (16 out of 18 patients) was observed in adult females with uncomplicated UTI. No patients complained of side effects due to fosfomycin trometamol.
Insights
Single oral doses of fosfomycin trometamol effectively treat lower urinary tract infections (UTIs), showing a 77% cure rate. This antibiotic therapy demonstrated particular success in adult females with uncomplicated UTIs, with no reported side effects.
Area of Science:
- Pharmacology
- Infectious Diseases
- Urology
Background:
- Lower urinary tract infections (UTIs) are common, prompting research into effective single-dose therapies.
- Fosfomycin trometamol is a phosphonic acid derivative investigated for UTI treatment efficacy.
Purpose of the Study:
- To evaluate the efficacy and safety of a single oral dose of fosfomycin trometamol for lower UTIs.
- To determine cure rates in a general patient population and specifically in adult females with uncomplicated UTIs.
Main Methods:
- A clinical trial involving 26 patients (5 males, 21 females) with lower UTIs.
- Treatment administered as a single oral dose of 3g fosfomycin trometamol.
- Patients were assessed for cure rates four weeks post-treatment.
Main Results:
- An overall cure rate of 77% (20/26 patients) was achieved four weeks after treatment.
- In adult females with uncomplicated UTIs, the cure rate was 89% (16/18 patients).
- No adverse side effects were reported by any patients receiving fosfomycin trometamol.
Conclusions:
- Single oral dose fosfomycin trometamol is an effective treatment for lower UTIs.
- The therapy shows high efficacy in adult females with uncomplicated UTIs.
- Fosfomycin trometamol is well-tolerated, with a favorable safety profile for UTI management.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Microbiota of the Urogenital Tract

